Search

Search Constraints

You searched for: Author/Creator Cmelak, Anthony

Search Results

2. A phase I study afatinib/carboplatin/paclitaxel induction chemotherapy followed by standard chemoradiation in HPV-negative or high-risk HPV-positive locally advanced stage III/IVa/IVb head and neck squamous cell carcinoma. (February 2016)

3. A phase I study afatinib/carboplatin/paclitaxel induction chemotherapy followed by standard chemoradiation in HPV-negative or high-risk HPV-positive locally advanced stage III/IVa/IVb head and neck squamous cell carcinoma. (February 2016)

4. Chemoradiotherapy with or without panitumumab in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-1): a randomised, controlled, open-label phase 2 trial. Issue 2 (February 2015)

5. Chemoradiotherapy with or without panitumumab in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-1): a randomised, controlled, open-label phase 2 trial. Issue 2 (February 2015)

6. Contemporary Management of Jugular Paragangliomas With Neural Preservation. (14th July 2020)

7. Contemporary Management of Jugular Paragangliomas With Neural Preservation. (February 2021)

8. Management of postradiation late hemorrhage following treatment for HPV‐positive oropharyngeal squamous cell carcinoma. Issue 5 (12th February 2022)

9. Panitumumab plus radiotherapy versus chemoradiotherapy in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-2): a randomised, controlled, open-label phase 2 trial. Issue 2 (February 2015)

10. Panitumumab plus radiotherapy versus chemoradiotherapy in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-2): a randomised, controlled, open-label phase 2 trial. Issue 2 (February 2015)